International Wastewater System (CSE:IWS) has announced it is collaborating with a licensed marijuana cultivator in the United States.
As quoted in the press release:

The collaboration enables IWS and the Cannabis Cultivation Facility to exchange data and evaluate the application of IWS’s thermal energy exchange technology in an industrial marijuana growing facility.
IWS has already demonstrated the environmental and economic benefits of its technology in a Canadian greenhouse installation at the Water Resource Centre in Sechelt, British Columbia (“Sechelt Greenhouse”). IWS installed a SHARC thermal energy exchange system at the Sechelt Greenhouse, which is connected to a primary building loop and used to reduce space heating, cooling & water heating costs at the greenhouse (see details: https://goo.gl/Mp0Z7u).
A study by scientist Evan Mills, with the Lawrence Berkeley National Laboratory, revealed that legalized indoor marijuana-growing operations account for 1% of total electricity use in the US, at a cost of $6bn per year. Annually, such consumption produces 15m tons of greenhouse gas emissions (CO2), equal to that of three million average cars.
IWS is working with the Cannabis Cultivation Facility to jointly evaluate the energy efficiency of IWS’s thermal exchange technology when integrated with the growing facility’s heating, ventilation and air conditioning (HVAC) infrastructure. IWS’s technology enables heating (heat transfer) and cooling (heat dissipation) applications, both a significant component of overall energy costs for the Cannabis Cultivation Facility.

Click here to read the full press release.


US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less